EcoDrugPlus

Somatostatin Receptor 2

Ensembl ID : ENSNBRG00000023375
Gene Symbol: SSTR2
3 Cross references
192 Possible Orthologues:

Somatostatin Receptor 5

Ensembl ID : ENSNBRG00000011294
Gene Symbol: SSTR5
3 Cross references
188 Possible Orthologues:

Somatostatin Receptor Type 3-Like

Ensembl ID : ENSNBRG00000012234
Gene Symbol: LOC102777686
2 Cross references
183 Possible Orthologues:

Squalene Synthase-Like

Ensembl ID : ENSNBRG00000018326
Gene Symbol: LOC102782155
3 Cross references
220 Possible Orthologues:

Steroid 17-Alpha-Hydroxylase/17,20 Lyase-Like

Ensembl ID : ENSNBRG00000019382
Gene Symbol: LOC102788784
3 Cross references
210 Possible Orthologues:

Sterol O-Acyltransferase 1-Like

Ensembl ID : ENSNBRG00000014020
Gene Symbol: LOC102796196
3 Cross references
210 Possible Orthologues:

Tachykinin Receptor 1

Ensembl ID : ENSNBRG00000011513
Gene Symbol: TACR1
3 Cross references
195 Possible Orthologues:

Tachykinin Receptor 3

Ensembl ID : ENSNBRG00000014315
Gene Symbol: TACR3
3 Cross references
208 Possible Orthologues:

Target Of Rapamycin Complex Subunit Lst8-Like

Ensembl ID : ENSNBRG00000019476
Gene Symbol: LOC102778919
3 Cross references
198 Possible Orthologues:

Telomerase Reverse Transcriptase-Like

Ensembl ID : ENSNBRG00000020336
Gene Symbol: LOC102791995
3 Cross references
189 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSNBRG00000015389
Gene Symbol: TBXAS1
1 Cross references
207 Possible Orthologues:

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSNBRG00000015334
Gene Symbol: TBXAS1
1 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).